[Federal Register Volume 68, Number 180 (Wednesday, September 17, 2003)]
[Notices]
[Page 54516]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-23633]


=======================================================================
-----------------------------------------------------------------------

SMALL BUSINESS ADMINISTRATION

[License No. 02/72-0609]


Wasserstein SBIC Ventures II, LP; Notice Seeking Exemption Under 
Section 312 of the Small Business Investment Act, Conflicts of Interest

    Notice is hereby given that Wasserstein SBIC Ventures II, LP, 1301 
Avenue of the Americas, 44th Floor, New York, New York 10019, a Federal 
Licensee under the Small Business Investment Act of 1958, as amended 
(``the Act''), in connection with the financing of a small concern, has 
sought an exemption under section 312 of the Act and section 107.730, 
Financings which Constitute Conflicts of Interest of the Small Business 
Administration (``SBA'') rules and regulations (13 CFR 107.730 (2001)). 
Wasserstein SBIC Ventures II, LP proposes to provide equity financing 
to Nephros, Inc., 2960 Broadway, New York, New York 10032. The 
financing is contemplated for general corporate purposes including 
product development and marketing.
    The financing is brought within the purview of section 
107.730(a)(1) of the Regulations because WPPN, LP, an Associate of 
Wasserstein SBIC Ventures II, LP, currently owns greater than 10 
percent of Nephros, Inc. and therefore Nephros, Inc. is considered an 
Associate of Wasserstein SBIC Ventures II, LP, as defined in section 
107.50 of the regulations.
    Notice is hereby given that any interested person may submit 
written comments on the transaction to the Associate Administrator for 
Investment, U.S. Small Business Administration, 409 Third Street, SW., 
Washington, DC 20416.

    Dated: September 11, 2003.
Jeffrey D. Pierson,
Associate Administrator for Investment.
[FR Doc. 03-23633 Filed 9-16-03; 8:45 am]
BILLING CODE 8025-01-P